Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127704081 | 12770408 | 1 | I | 20160722 | 20160920 | 20160922 | 20160922 | EXP | MX-ROCHE-1833426 | ROCHE | 48.24 | YR | M | Y | 179.00000 | KG | 20160922 | CN | MX | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127704081 | 12770408 | 1 | PS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | CURRENTLY ONGOING | 103964 | 180 | UG | SOLUTION FOR INJECTION | /wk | ||||||
| 127704081 | 12770408 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | TWO AT MORNING, TWO AT NOON, TWO AT NIGHT. ONGOING | 21511 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127704081 | 12770408 | 1 | Hepatitis C |
| 127704081 | 12770408 | 2 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127704081 | 12770408 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127704081 | 12770408 | Arthralgia | |
| 127704081 | 12770408 | Bone pain | |
| 127704081 | 12770408 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127704081 | 12770408 | 1 | 20160722 | 0 | ||
| 127704081 | 12770408 | 2 | 20160722 | 0 |